Results

eNauka >  Rezultati >  What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia
Naziv: What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia
Autori: Adžić-Vukičević, Tatjana N.  ; Marković, Dejan  ; Reljić, Aleksandar; Brković, Voin
Godina: 2023
Publikacija: Frontiers in medicine
ISSN: 2296-858X Frontiers in Medicine Pretraži identifikator
Izdavač: Lausanne, Switzerland : Frontiers Media S.A.
Tip rezultata: Naučni članak
Kolacija: vol. 10 str. 1253135
DOI: 10.3389/fmed.2023.1253135
WoS-ID: 001170469700001
Scopus-ID: 2-s2.0-85178030659
PMID: 38034537
PMCID: PMC10683091
URI: https://enauka.gov.rs/handle/123456789/939037
URL: https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1253135/full
Projekat: Ministry of Health10.13039/501100004726
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21aM21a - Vodeći međunarodni časopis kategorije M21a

Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.